Skip to Content

Notice

Memorandum of Understanding Between the Food and Drug Administration and the Health Products and Food Branch, Health Canada of Canada Regarding Sharing and Exchange of Information about Therapeutic Products

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

Food and Drug Administration, HHS.

ACTION:

Notice.

SUMMARY:

The Food and Drug Administration is providing notice of a memorandum of understanding (MOU) between the Food and Drug Administration (FDA), Department of Health and Human Services of the United States of America and the Health Products and Food Branch, Health Canada of Canada. The purpose of this MOU is to enhance and strengthen the exchange of information and existing public health protection cooperative activities related to the regulation of the specified therapeutic products.

DATES:

The agreement became effective November 18, 2003.

Start Further Info

FOR FURTHER INFORMATION CONTACT:

Beverly Corey, Office of International Programs ( HFG-1), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-0855.

End Further Info End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

In accordance with 21 CFR 20.108(c), which states that all written agreements and MOUs between FDA and others shall be published in the Federal Register, the agency is publishing notice of this MOU.

Start Signature

Dated: December 17, 2003.

Jeffrey Shuren,

Assistant Commissioner for Policy.

End Signature Start Printed Page 75582

Start Printed Page 75583

Start Printed Page 75584

Start Printed Page 75585

End Supplemental Information

BILLING CODE 4160-01-S

[FR Doc. 03-32104 Filed 12-30-03; 8:45 am]

BILLING CODE 4160-01-C